Katie Rubino is a Partner in the Corporate Department.

Katie frequently represents clients on target discovery collaborations, assisting in structuring spin-offs, divestitures, and out-licensing from pharma, hospital systems, and academic research institutions. She also counsels life sciences companies developing pharmaceuticals, vaccines, medical devices, antibody products, digital health, and medical devices and advises companies raising growth capital, merger and acquisition transactions, and initial public offerings. Katie is experienced in transactions involving intellectual property rights, strategic partnerships, licensing, and research collaborations.

Katie is active in industry organizations and chairs the American Chemical Society’s Chemistry and the Law Division. She speaks frequently on intellectual property and life sciences at MIT, Harvard, Yale, and Northeastern, and has been featured in The Wall Street Journal, Fox Business, and Corporate Compliance Insights. She co-authored You Are an IP Company: The 12-Step Plan to Increase Your Intellectual Property Influence, Impact, and Income and co-hosts the You Are an IP Company podcast (Apple Podcasts, Spotify, and YouTube).

Katie holds a J.D. from Suffolk University Law School, a Doctor of Pharmacy from Northeastern University, and is dually qualified to practice in both the United States and England and Wales.